| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/21/2008 | EP1923060A1 Combinations of a sphingolipid and an HMG-CoA reductase inhibitor for treating hypercholesterolemia |
| 05/21/2008 | EP1922304A2 Processes for the preparation of (3r,4s)-4-((4-benzyloxy)phenyl)-1-(4-fluorophenyl)-3-((s)-3-(4-fluorophenyl)-3-hydroxypropyl)-2-azetidinone, an intermediate for the synthesis of ezetimibe |
| 05/21/2008 | EP1922086A1 Targeted protein kinase c inhibitors and uses thereof |
| 05/21/2008 | EP1922065A2 Novel formulations comprising fenofibrate and a statin, and related methods of treatment |
| 05/21/2008 | EP1921919A2 Sustained release enhanced lipolytic formulation for regional adipose tissue treatment |
| 05/21/2008 | EP1921917A2 Fused aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 05/21/2008 | EP1681296B1 Epimeredi glycoside a, the formulation containing thereof and their preparation method |
| 05/21/2008 | EP1562958B1 N-sulfonylaminothiazole |
| 05/21/2008 | EP1562595B1 Diaryl ethers as opioid receptor antagonists |
| 05/21/2008 | EP1482924B1 Cathepsin cysteine protease inhibitors |
| 05/21/2008 | EP1444228B1 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors |
| 05/21/2008 | EP1434773B1 Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
| 05/21/2008 | EP1385508B1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 05/21/2008 | EP1379492B1 Inhibitor of monoamine uptake |
| 05/21/2008 | EP1362027B1 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 05/21/2008 | EP1313453B1 Particulate vectors for improving oral absorption of active principles |
| 05/21/2008 | EP1287130B1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 05/21/2008 | EP1284734B1 Isoquinoline derivatives as protein kinase inhibitors |
| 05/21/2008 | EP1272048B1 Method for the fractionation of oil and polar lipid-containing native raw materials |
| 05/21/2008 | EP1261586B1 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase iv, processes for their preparation, and their use |
| 05/21/2008 | EP0924986B1 Antioxidant derived from lentil and its preparation and uses |
| 05/21/2008 | CN101184753A Novel mchr1 antagonists and their use for the treatment of mchr1 mediated conditions and disorders |
| 05/21/2008 | CN101184543A Method of preparing lycopene-enriched formulations that are free of organic solvents, formulations thus obtained, compositions comprising said formulations and use of same |
| 05/21/2008 | CN101184509A Agent for improvement of insulin resistance |
| 05/21/2008 | CN101184499A Intranasal administration of active agents to the central nervous system |
| 05/21/2008 | CN101184496A Pharmaceutical preparation for recovery from fatigue |
| 05/21/2008 | CN101182562A Method for producing extracellular polysaccharide through golden fungus liquid fermentation and uses thereof |
| 05/21/2008 | CN101182557A Preparation method of malic acid-calcium amino acid |
| 05/21/2008 | CN101182430A Health-care multipurpose washing liquor and method for making same |
| 05/21/2008 | CN101182317A Sulfur-containing proanthocyanidin oligomer composition and production method thereof |
| 05/21/2008 | CN101181630A Method for preparing collagen polypeptide products as well as usage |
| 05/21/2008 | CN101181550A Chinese medicine prescription for dropping blood fat and preparation method |
| 05/21/2008 | CN101181545A Medicinal composition orally taken for treating diabetes |
| 05/21/2008 | CN101181539A New use of chinese medicine composition |
| 05/21/2008 | CN101181520A Chinese traditional medicine tonic wine for tonifying kidney and nourishing blood |
| 05/21/2008 | CN101181519A Hongxue Tea particle for curing hypertension and hyperlipemia |
| 05/21/2008 | CN101181515A Hypoglycemic health care medicine and preparation method thereof |
| 05/21/2008 | CN101181491A Method for preparing jiang-zhi-yin capsule |
| 05/21/2008 | CN101181463A Chinese medicine composition for treating diabetes and method for preparing the same |
| 05/21/2008 | CN101181461A Chinese medicine emplastrum for slimming and removing fat |
| 05/21/2008 | CN101181446A Application of sitsang scindapsus aureus flower as well as extract thereof in the preparation of diabetes medicament |
| 05/21/2008 | CN101181403A Pharmaceutical combination for curing hyperlipemia symptoms and preparation method thereof |
| 05/21/2008 | CN101181373A Cortex moutan valid target pharmaceutical combination, preparation method and application thereof |
| 05/21/2008 | CN101181336A Method for refining valid target of bitter gourd for dropping blood sugar |
| 05/21/2008 | CN101181318A Shanlu Tea extract for dropping blood pressure and blood fat as well as preparation method thereof |
| 05/21/2008 | CN101181314A Method for preparing folium ginkgo extract from Hericium erinaceus and usage |
| 05/21/2008 | CN101181306A Nano-scale compound pearl dimension C lozenge and preparation method thereof |
| 05/21/2008 | CN101181299A Nano-scale inorganic nutrition hardening agent |
| 05/21/2008 | CN101181292A Tea polyoses oral liquid |
| 05/21/2008 | CN101181291A Tea polyoses injection |
| 05/21/2008 | CN101181289A Injection of 13 kinds complex vitamin and preparing technique thereof |
| 05/21/2008 | CN101181286A Medicinal composition for treating diabetes |
| 05/21/2008 | CN101181264A Pharmaceutical composition taking metformin hydrochloride and vigelegting as active component as well as preparing method and uses thereof |
| 05/21/2008 | CN101181258A Lysinepuzinc oral liquid and preparation method thereof |
| 05/21/2008 | CN101181254A Slimming appetising capsule containing natural capsicine for promoting blood circulation and reducing blood fat |
| 05/21/2008 | CN101181236A Exendin agonist peptide formulations and administration method thereof |
| 05/21/2008 | CN100389194C Insulin secretory cell extract and its application in inducing stem cell differentiation |
| 05/21/2008 | CN100389192C Substances for preventing and treating autoimmune diseases |
| 05/21/2008 | CN100389113C Nitrogenous heterocyclic compound and medicine containing the same |
| 05/21/2008 | CN100388951C Dietetic food composition and dietetic method using such composition |
| 05/21/2008 | CN100388950C Application of human urokinase-type peptidase in preparing medicine for treating diabetes combined cerebral infraction |
| 05/21/2008 | CN100388938C Capsule for treating diabetic coronary heart disease |
| 05/21/2008 | CN100388929C Medicine for treating hyperlipidemia |
| 05/21/2008 | CN100388920C Oral administration dual polysaccharide Chinese medicine and its preparation method |
| 05/20/2008 | US7375238 Process for the preparation of N-substituted 2-cyanopyrrolidines |
| 05/20/2008 | US7375231 Intermediate compound which is used for the preparation of pioglitazone |
| 05/20/2008 | US7375215 Compounds for PDT |
| 05/20/2008 | US7375205 Elongase genes and uses thereof |
| 05/20/2008 | US7375135 Fatty acid derivatives; preparation and uses thereof |
| 05/20/2008 | US7375134 N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)-1,1'-biphenyl-4-yl]ethyl}-L-leucinamide; osteoporosis and other bone loss disorders |
| 05/20/2008 | US7375131 NF-κB inhibitors |
| 05/20/2008 | US7375128 Inhibitors of α1 β2 integrin mediated cell adhesion |
| 05/20/2008 | US7375124 2-[3-[2-(4-chlorophenyl)ethoxy]phenylthio]-2-methyl-propanoic acid; antidaibetic agent; insulin resistance, hyperlipemia; increasing HDL-cholesterol levels; low toxicity; microvascular (diabetic retinopathy, neuropathy, nephropathy) and macrovascular (atherosclerosis, obesity, stroke) complications |
| 05/20/2008 | US7375123 1,2,4-thiadiazole derivatives as melanocortin receptor modulators |
| 05/20/2008 | US7375116 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
| 05/20/2008 | US7375113 Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
| 05/20/2008 | US7375111 Compositions for affecting weight loss |
| 05/20/2008 | US7375087 prevention or treatment of disease associated with hyperglycemia: diabetes, impaired glucose tolerance, impaired fasting glycemia, diabetic complications or obesity; e.g. 4-[(4-{3-[1-carbamoyl-1-(methyl)-ethylcarbamoyl]propyl}-2-methylphenyl)methyl]-3-( beta -D-glucopyranosyloxy)-5-isopropyl-1H-pyrazole |
| 05/20/2008 | US7375074 Ligand which binds to polypeptides; controlling eating disorders; screening process |
| 05/20/2008 | US7374892 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases |
| 05/20/2008 | US7374891 Receptor for Advanced Glycated Endproducts (RAGE); detecting binding of ligand and protein in presence of peptide, lipid, carbohydrate; amyloid, high-throughput colorimetric assay |
| 05/20/2008 | CA2432223C Pyrazole compounds useful as protein kinase inhibitors |
| 05/20/2008 | CA2430065C Salts of a isothiazole-4-carboxamide and their use as anti-hyperproliferation agents |
| 05/20/2008 | CA2415681C Pyrrolidine derivatives |
| 05/20/2008 | CA2385440C 5-hydroxysapogenin derivatives with anti-dementia activity |
| 05/20/2008 | CA2269089C Sodium salt of [poly-(2,5-dihydroxyphenylene)]-4-thiosulphuric acid of linear structure as regulator of cell metabolism and production method thereof |
| 05/20/2008 | CA2231971C Hypolipidemic 1,4-benzothiazepine-1,1-dioxides |
| 05/15/2008 | WO2008058127A2 Agonist trkb antibodies and uses thereof |
| 05/15/2008 | WO2008057681A2 Thiophene compounds |
| 05/15/2008 | WO2008057282A1 Calcium receptor modulating agents |
| 05/15/2008 | WO2008057136A1 Oral care compositions containing combinations of anti-bacterial and host-response modulating agents |
| 05/15/2008 | WO2008056726A1 Glp-1 derivative and use thereof |
| 05/15/2008 | WO2008056687A1 Novel spiropiperidine derivative |
| 05/15/2008 | WO2008056634A1 Novel hydroxyindole derivative |
| 05/15/2008 | WO2008056450A1 Blood neutral fat level-lowering agent, hdl cholesterol level-increasing agent, and arterial stiffness index-lowering agent |
| 05/15/2008 | WO2008055940A2 Combination therapy with sglt-2 inhibitors and their pharmaceutical compositions |
| 05/15/2008 | WO2008055801A2 Antidiabetogenic calcium-peptide composition |
| 05/15/2008 | WO2008055445A1 Method and composition for increasing insulin sensitivity |
| 05/15/2008 | WO2008038305A3 Therapeutical formulation comprising a thiazolidinedione and a nitric oxide scavenger. |
| 05/15/2008 | WO2008038303A3 Therapeutic formulation comprising a sulfonylurea, a thiazolidinedione and a nitric oxide scavenger. |